BridgeMD
Tests treatment safety and results for Acute Cholangitis
Official title Comparative Efficacy Of Intraductal Antibiotic During ERCP In Acute Cholangitis
ClinicalTrials.gov ID: NCT07407491
What this study is testing
What is Gentamicin - single dose?
Gentamicin - single dose is an investigational medicine, being studied as a potential treatment for acute cholangitis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Does intraductal administration of antibiotics during endoscopic retrograde cholangiopancreatography (ERCP), in addition to standard systemic antibiotic therapy, improve clinical outcomes in patients with acute cholangitis compared with standard systemic antibiotic therapy alone?
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- The patients diagnosed with mild and moderate acute cholangitis based on TG 18
- Planned for ERCP within 48 hours
- 18 years old and above
You likely can't join if
- Severe acute cholangitis
- History of antibiotic hypersensitivity
- Receiving cancer chemotherapy, steroids, or immunosuppressive agents
- Concomitant infections
- Recent biliary interventions such as percutaneous transhepatic biliary drainage (PTBD) within last 3 months
- Known or suspected perforated tympanic membrane, myasthenia gravis
The study team makes the final eligibility decision.
Where it's taking place
- Cheras, Kuala Lumpur, Malaysia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cheras, Kuala Lumpur, Malaysia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.